• No results found

hemophilia B

Manual therapy in the treatment of patients with hemophilia B and inhibitor

Manual therapy in the treatment of patients with hemophilia B and inhibitor

... with hemophilia B and inhibitor received physiotherapy treatment based on manual therapy for 3 months, with a frequency of 2 sessions per ...the Hemophilia Joint Health Score; pain was assessed with ...

5

Treatment of hemophilia B: focus on recombinant factor IX

Treatment of hemophilia B: focus on recombinant factor IX

... Abstract: Hemophilia B is a recessive X-linked bleeding disorder characterized by deficiency of the coagulation factor IX ...In hemophilia B patients the severity of the bleeding phe- notype ...

6

Mild-severe hemophilia B impacts relationships of US adults and children with hemophilia B and their families: results from the B-HERO-S study

<p>Mild-severe hemophilia B impacts relationships of US adults and children with hemophilia B and their families: results from the B-HERO-S study</p>

... that hemophilia affected their ability to form close relationships with partners or prospective partners; 35% were very/quite dissatis fi ed with the support received from a previous ...their hemophilia ...

10

Molecular Characterization of the Factor IX Gene in 28 Iranian Hemophilia B Patients

Molecular Characterization of the Factor IX Gene in 28 Iranian Hemophilia B Patients

... Hemophilia B, or Christmas disease, is an X- linked coagulopathy due to the deficiency or functional abnormality of clotting factor IX ...of hemophilia B is approximately one in 25000-30000 ...

5

Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion

Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion

... A partial gene product was identified in a pedigree with hemophilia B due to a partial deletion of the Factor IX gene (Chen, S.-H.,S. Yoshitake, P.F. Chance, G.L. Bray, A.R. Thompson, C.R. Scott, and K. ...

8

GlycoPEGylated recombinant factor IX for hemophilia B in context

GlycoPEGylated recombinant factor IX for hemophilia B in context

... over hemophilia treatment selection and switching involve balancing many clinical and patient-related ...philia B is prophylaxis with plasma-derived or recombinant factor IX (rFIX) ...with hemophilia ...

11

New developments in the management of moderate-to-severe hemophilia B

New developments in the management of moderate-to-severe hemophilia B

... Abstract: Hemophilia B is an X-linked genetic deficiency of coagulation factor IX (FIX) activity associated with recurrent deep tissue and joint bleeding that may lead to long-term ...from hemophilia ...

12

Correlations between patient-reported outcomes and self-reported characteristics in adults with hemophilia B and caregivers of children with hemophilia B: analysis of the B-HERO-S study

<p>Correlations between patient-reported outcomes and self-reported characteristics in adults with hemophilia B and caregivers of children with hemophilia B: analysis of the B-HERO-S study</p>

... the B-HERO-S study have been previously ...for Hemophilia B, Hemophilia Federation of America, and National Hemophilia ...with hemophilia B (n=299) or caregivers of a ...

16

Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B

Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B

... with hemophilia A received the ...in hemophilia B versus 53% in hemophilia A) and also present in patients > 18 years of age (20% versus ...Moderate hemophilia B is diagnosed ...

8

Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor

Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor

... Hemophilia B can be divided into at least two mutant forms different from the mild, moderate, and severe categories previously ...of hemophilia B patients, PTC-inhibitor-neutralizing activity ...

7

Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients

Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients

... shown to have total deletions of the factor IX gene. Two other inhibitor patients, the brothers, were shown to have a presumably identical complex rearrangement of the factor IX gene involving two separate deletions. The ...

9

Developments in the treatment of hemophilia B: focus on emerging gene therapy

Developments in the treatment of hemophilia B: focus on emerging gene therapy

... Abstract: Hemophilia B is a genetic disorder that is characterized by a deficiency of clotting factor IX (FIX) and excessive ...with hemophilia B are ideal candidates for gene therapy, mostly ...

11

An intragenic deletion of the factor IX gene in a family with hemophilia B

An intragenic deletion of the factor IX gene in a family with hemophilia B

... A family of seven patients severely afflicted with hemophilia B has been studied for their factor IX genes through the use of factor IX cDNA and genomic DNA probes. The patients had detectable (less than ...

5

Hemophilia B (Christmas Disease) in a Female

Hemophilia B (Christmas Disease) in a Female

... philia B, with a great amount of in-breeding, have been investigated,12hi no case of homo- zygous hemophilia B in a female due to mating between a hemophilic father and a carrier.. mothe[r] ...

6

Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene

Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene

... coagulation and immunological assays, to follow the segregation of an abnormal FIX gene in a large Hemophilia B family. Among the six potential female carriers, functional assays showed that four had a high ...

6

Unmasking Acquired hemophilia B disguised in an elderly male on Warfarin treatment – a case report and literature review.

Unmasking Acquired hemophilia B disguised in an elderly male on Warfarin treatment – a case report and literature review.

... Patient was diagnosed as acquired Hemophilia B and was restored on Warfarin therapy. Factor IX monitoring was advised instead of the conventional care to keep INR within the target range. Patient was ...

5

To study the occurrence of inhibitors in children affected with hemophilia ‘A’ and hemophilia ‘B’ disease

To study the occurrence of inhibitors in children affected with hemophilia ‘A’ and hemophilia ‘B’ disease

... 100 hemophilia patients attending OPD (81hemophilia A and 19 hemophilia B) in 2012-2013 were screened for presence of ...from hemophilia patients were appropriately processed, stored and sent ...

5

Hemophilia B: Molecular pathogenesis and mutation analysis

Hemophilia B: Molecular pathogenesis and mutation analysis

... with hemophilia B in whom mutations have not been identified by F9 genomic DNA ...to hemophilia A, few studies have been published on F9 cDNA ...

12

Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes

Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes

... Studies using both the genomic and cDNA probes confirmed that the variant 1.8-kb fragment was present in each obligate carrier and in each of the two carriers identified by RFLP analysis[r] ...

7

Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection: a nested cross-sectional study

Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection: a nested cross-sectional study

... had hemophilia A (factor VIII defi- ciency). Because patients with hemophilia A generally required more intensive clotting factor replacement ther- apy as well as product (Factor VIII concentrate) that was ...

5

Show all 10000 documents...

Related subjects